Cargando…

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab

Detalles Bibliográficos
Autores principales: Park, Jonathan J., Park, Eunsuh, Damsky, William E., Vesely, Matthew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275729/
https://www.ncbi.nlm.nih.gov/pubmed/37332364
http://dx.doi.org/10.1016/j.jdcr.2023.05.004
_version_ 1785059929387696128
author Park, Jonathan J.
Park, Eunsuh
Damsky, William E.
Vesely, Matthew D.
author_facet Park, Jonathan J.
Park, Eunsuh
Damsky, William E.
Vesely, Matthew D.
author_sort Park, Jonathan J.
collection PubMed
description
format Online
Article
Text
id pubmed-10275729
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102757292023-06-18 Pembrolizumab-induced lichenoid dermatitis treated with dupilumab Park, Jonathan J. Park, Eunsuh Damsky, William E. Vesely, Matthew D. JAAD Case Rep Case Series Elsevier 2023-05-16 /pmc/articles/PMC10275729/ /pubmed/37332364 http://dx.doi.org/10.1016/j.jdcr.2023.05.004 Text en © 2023 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Series
Park, Jonathan J.
Park, Eunsuh
Damsky, William E.
Vesely, Matthew D.
Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
title Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
title_full Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
title_fullStr Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
title_full_unstemmed Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
title_short Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
title_sort pembrolizumab-induced lichenoid dermatitis treated with dupilumab
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275729/
https://www.ncbi.nlm.nih.gov/pubmed/37332364
http://dx.doi.org/10.1016/j.jdcr.2023.05.004
work_keys_str_mv AT parkjonathanj pembrolizumabinducedlichenoiddermatitistreatedwithdupilumab
AT parkeunsuh pembrolizumabinducedlichenoiddermatitistreatedwithdupilumab
AT damskywilliame pembrolizumabinducedlichenoiddermatitistreatedwithdupilumab
AT veselymatthewd pembrolizumabinducedlichenoiddermatitistreatedwithdupilumab